# Phase II Clinical Trial of Clenbuterol in Adult Patients With Pompe Disease

> **NCT04094948** · PHASE2 · WITHDRAWN · sponsor: **Duke University**

## Conditions studied

- Pompe Disease (Late-onset)

## Interventions

- **DRUG:** Clenbuterol
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT04094948
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-01-01
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** hasn't got the funding
- **Last updated:** 2022-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04094948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04094948, "Phase II Clinical Trial of Clenbuterol in Adult Patients With Pompe Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04094948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*